For NVIDIA (NVDA), look to fade sharp post-earnings spikes while holding for long-term growth, as projected 70% revenue expansion in fiscal 2028 outweighs near-term gross margin pressure.

Sell or short Salesforce (CRM) around the $231 post-earnings level, where the recent double-digit rally appears driven by short-covering rather than strong underlying growth.

Maintain a high-conviction short position on Moderna (MRNA) to profit from ongoing cash burn and declining core franchise revenues.

Deploy conservatively sized short trades on Capricor Therapeutics (CAPR) due to high skepticism surrounding lead asset FDA approval, while strictly managing risk against potential short squeezes.

Look for tactical intraday short setups on Meta Platforms (META) during market pullbacks as the stock absorbs headwinds from a potential $16 billion regulatory settlement.

NVIDIA (NVDA)

• Q2 Financial Performance: NVIDIA reported $96.2 billion in quarterly revenue (exceeding consensus estimates of $92.2 billion), driven by $89 billion in Data Center revenue.
• Guidance & Outlook:
  • Q3 revenue guidance was set at $108 billion, well above street expectations.
  • Full-year fiscal 2028 revenue is projected to grow approximately 70% year-over-year, constrained entirely by supply bottlenecks despite underlying demand growth exceeding 100%.
  • Capital expenditure from major hyperscalers (Microsoft, Amazon, Google, Meta) and Tier-2 "Neoclouds" continues to expand aggressively.
• Architecture Ramp: The upcoming Vera Rubin architecture expands revenue opportunity to $40 billion per gigawatt of data center capacity (up from $25 billion with Grace Blackwell and $18 billion with Hopper).
• Margin Pressure: High Bandwidth Memory (HBM) and DRAM pricing spikes are compressing gross margins, which are guided to decline to 74% in Q3, bottoming out around 71%–72% in Q4 before rebounding to 72%–73% in fiscal 2028.
• Earnings Trading Strategy: Analysis of past earnings cycles indicates a frequent pattern of "fading the print" (selling into post-announcement spikes or buying extreme initial panic dips, as after-hours moves often reverse into the next full trading session).

Takeaways

• Long-term structural demand remains intact across both enterprise AI and sovereign infrastructure, but near-term gross margin compression from rising memory input costs could limit valuation multiple expansion.
• Short-term options strategies (such as straddles) during earnings announcements often face elevated implied volatility crush; historical post-earnings price swings frequently revert toward mean levels the following trading day.

Salesforce (CRM)

• Post-Earnings Price Action: Following quarterly results, the stock experienced an immediate after-hours rally between 7% and 12% to roughly $231.
• Fundamental Sentiment: Martin expressed skepticism regarding the quality of the beat, viewing the earnings rally as an overreaction driven by short-covering across enterprise software names.
• Trade Execution: Initiated a short position to fade the post-earnings pop.

Takeaways

• Be cautious chasing post-earnings pops in legacy SaaS companies where revenue growth acceleration may not fundamentally justify sudden double-digit price expansions.

Moderna (MRNA)

• Bearish Positioning: Martin maintained an active short stance on MRNA, criticizing market commentary that labeled the stock as "cheap."
• Capital Structure & Cash Burn: Suggested that Moderna missed opportunities to raise capital via secondary offerings or convertible debt to shore up its balance sheet ahead of operational slowdowns.
• Volatility: High implied volatility provides active trading swings, but the mid-term fundamental bias remains negative.

Takeaways

• High cash burn and declining core franchise revenues present ongoing headwinds; short-sellers continue to target rallies despite sharp intermittent volatility bounces.

Capricor Therapeutics (CAPR)

• Regulatory Skepticism: Martin reiterated a heavy short thesis, claiming the company's lead pipeline candidates will fail to secure FDA approval.
• Short Squeeze Dynamics: Acknowledged that low-float biotech names frequently experience violent short squeezes and mini-runs.
• Risk Management: Emphasized strict position sizing (e.g., maintaining conservative leverage and capital allocation) to withstand temporary volatility spikes in clinical-stage biotech shorts.

Takeaways

• Clinical-stage biotech short positions carry substantial tail risk due to sudden retail squeezes and binary regulatory events; disciplined position sizing is critical.

Broadcom (AVGO)

• Custom Silicon Dynamics: Highlighted mixed catalysts for Broadcom's application-specific integrated circuit (ASIC) division.
• Competitive Headwinds & Gains: While Broadcom stands to capture new custom AI processor contracts with frontier labs like OpenAI, it faces potential margin and volume uncertainty as Google diversifies its custom TPU production across competing design partners such as MediaTek.

Takeaways

• Broadcom maintains a strong networking and custom silicon foothold, but investors should monitor client concentration and potential loss of exclusivity among major cloud hyperscaler chip contracts.

Meta Platforms (META)

• Intraday Weakness: Traded under pressure following reports surrounding massive regulatory settlement figures (up to $16 billion) and operational challenges regarding AI-driven workforce transitions.
• Trading Sentiment: Identified as a viable short intraday setup when broad market indices show signs of fatigue and large-cap tech leadership stalls.

Takeaways

• Extended regulatory overhangs and potential restructuring friction can create tactical short-term trading opportunities on the short side, even within dominant mega-cap tech balance sheets.

Silicon Photonics & Optical Computing (Emerging Sector)

• Architectural Shift in AI Hardware: Modern electronic GPUs are limited by algorithmic matrix multiplication complexity running in roughly $O(N^3)$ time. Optical/photonic computing utilizes light diffraction to perform matrix vector multiplications nearly instantaneously in $O(N)$ complexity.
• Startups to Watch: Highlighted venture-backed private hardware companies such as Neurophos and Opticor developing optical compute chips to address power and interconnect limits in AI data centers.
• Long-Term Outlook: Silicon photonics is viewed as a more commercially viable and near-term technology platform than quantum computing for standard AI workloads.

Takeaways

• Optical interconnects and silicon photonics represent a vital high-growth hardware sub-sector designed to bypass traditional power and bandwidth walls in modern data centers.

Speculative Micro-Cap Tokens & Meme Coins (Pump.fun / Solana Ecosystem)

• Market Dynamics: Discussed and traded hyper-speculative micro-cap tokens (e.g., SUS, H1ghr) launched via automated bonding-curve platforms.
• Structural Risks:
  • Extreme liquidity fragmentation and rapid pump-and-dump lifecycles.
  • Highly concentrated supply structures (creators and early buyers controlling 25%–70% of available float).
  • Heavy reliance on social media "raids" and livestreams to generate exit liquidity for early holders.

Takeaways

• Micro-cap meme tokens operate almost purely as player-versus-player (PvP) momentum trades without fundamental underlying value; participants face severe slippage, rug-pull risks, and rapid capital depreciation.